Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor

This publication has 36 references indexed in Scilit:

• Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET
  European Journal of Nuclear Medicine and Molecular Imaging, 2009
• A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-¹¹C-Verapamil and PET
  Journal of Nuclear Medicine, 2009
• Synthesis and Small-Animal Positron Emission Tomography Evaluation of [¹¹C]-Elacridar As a Radiotracer to Assess the Distribution of P-Glycoprotein at the Blood−Brain Barrier
  Journal of Medicinal Chemistry, 2009
• Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats
  Nuclear Medicine and Biology, 2009
• P-Glycoprotein Function at the Blood–Brain Barrier Imaged Using ¹¹C-N-Desmethyl-Loperamide in Monkeys
  Journal of Nuclear Medicine, 2008
• Synthesis and Evaluation of [N-methyl-¹¹C]N-Desmethyl-loperamide as a New and Improved PET Radiotracer for Imaging P-gp Function
  Journal of Medicinal Chemistry, 2008
• Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood–Brain Barrier Studied with (R)-¹¹C-Verapamil and PET
  Journal of Nuclear Medicine, 2008
• Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy
  Pharmacological Reviews, 2008
• P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of Topotecan
  Clinical Cancer Research, 2007
• Targeting multidrug resistance in cancer
  Nature Reviews Drug Discovery, 2006